Recchia, Daisy
Baghdadli, Amaria
Lassale, Camille
Brunner, Eric
Verdier, Jean-Michel
Kivimäki, Mika
Akbaraly, Tasnime
Funding for this research was provided by:
Medical Research Council (MR/K013351, MR/R024227/1)
British Heart Fundation (PG/11/63/29011)
National Institute on Aging (R01AG013196)
National Heart, Lung, and Blood Institute ch Institute (R01HL036310)
CoeN (n/a)
Article History
Received: 23 October 2018
Accepted: 3 April 2019
First Online: 13 April 2019
Compliance with ethical standards
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest.
: The Whitehall II study has been supported by grants from the British Medical Research Council (MR/K013351 and MR/R024227/1); the British Heart Foundation (PG/11/63/29011 and RG/13/2/30098); the British Health and Safety Executive; the British Department of Health; the National Heart, Lung, and Blood Institute (R01HL036310); the National Institute on Aging, National Institute of Health (R01AG013196, R01 AG034454); the Economic and Social Research Council (ES/J023299). Mika Kivimaki is supported by the Medical Research Council (K013351 and MR/R024227/1), UK; NordForsk, the Nordic Research Programme on Health and Welfare, and Helsinki Institute of Life Sciences Fellowship. Tasnime Akbaraly is supported by the CoEN of Montpellier (Centre d’Excellence CoEN de Montpellier). The funding organization or sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.